Genomic profiling of papillary renal cell tumours identifies small regions of DNA alterations: A possible role of HNF1B in tumour development

Histopathology

Volumn 58, Issue 6, 2011, Pages 934-943

  Szponar, Adrianna ^a   Yusenko, Maria V ^a   Kuiper, Roland ^b   van Kessel, Ad Geurts ^b   Kovacs, Gyula ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Array CGH; HNF1B; Immunohistochemistry; Papillary renal cell tumour; Precursor lesion

Indexed keywords

GENOMIC DNA; HEPATOCYTE NUCLEAR FACTOR 1BETA; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHROMOSOME 17; CHROMOSOME 7; CHROMOSOME DUPLICATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA SEQUENCE; FEMALE; FETUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY PROXIMAL TUBULE; MALE; MUCINOUS CARCINOMA; MUCINOUS TUBULAR AND SPINDLE CELL CARCINOMA; NEPHROBLASTOMA; PAPILLARY RENAL CELL TUMOR; PRECANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINDLE CELL CARCINOMA; TISSUE MICROARRAY; TRISOMY;

ADENOCARCINOMA, MUCINOUS; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 7; DNA, NEOPLASM; FEMALE; GENE DUPLICATION; GENE EXPRESSION PROFILING; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRISOMY;

BACTERIA (MICROORGANISMS);

EID: 79956120358     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03795.x     Document Type: Article

References (30)

1. Kovacs G. Papillary renal cell carcinoma: a morphologic and cytogenetic study of 11 cases. Am. J. Pathol. 1989; 34; 27-34.
2. Kovacs G, Füzesi L, Emanuel A, Kung H. Cytogenetics of papillary renal cell tumors. Genes Chromosom. Cancer 1991; 3; 249-255.
3. Palmedo G, Fischer J, Kovacs G. Fluorescent microsatellite analysis reveals duplication of specific chromosomal regions in papillary renal cell tumors. Lab. Invest. 1997; 77; 633-638.
4. Balint I, Szponar A, Jauch A, Kovacs G. Trisomy 7 and 17 mark papillary renal cell tumours irrespectively of variation of the phenotype. J. Clin. Pathol. 2009; 10; 892-895.
5. Balint I, Fischer J, Ljungberg B, Kovacs G. Mapping the papillary renal cell carcinoma gene between loci D17S787 and D17S1799 on chromosome 17q21.32. Lab. Invest. 1999; 79; 1713-1718.
6. Bentz M, Bergerheim USR, Li C et al. Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization. Cytogenet. Cell Genet. 1996; 75; 17-21.
7. Glukhova L, Goguel AF, Chudoba I et al. Overrepresentation of 7q31 and 17q in renal cell carcinoma. Genes Chromosom. Cancer 1998; 22; 171-178.
8. Kovacs G, Tory K, Kovacs A. Development of papillary renal cell tumours is associated with loss of Y-chromosomespecific DNA sequences. J. Pathol. 1994; 173; 39-44.
9. Schmidt L, Duh FM, Chen F et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 1997; 16; 68-73.
10. Fischer J, Palmedo G, von KnoblochR et al. Duplication and overexpression of the mutated allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours. Oncogene 1998; 17; 733-739.
11. Szponar A, Zubakov D, Pawlak J, Jauch A, Kovacs G. Three genetic developmental stages of papillary renal cell tumours: duplication of chromosome 1q marks fatal progression. Int. J. Cancer 2009; 124; 2071-2076.
12. Vissers LELM, de VriesBBA, Osoegawa K et al. Array based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am. J. Hum. Genet. 2003; 73; 1261-1270.
13. de VriesBBA, Pfundt R, Leisink M et al. Diagnostic genome profiling in mental retardation. Am. J. Hum. Genet. 2005; 77; 606-616.
14. Lubensky IA, Schmidt L, Zhuang Z et al. Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. Am. J. Pathol. 1999; 155; 517-526.
15. Zhuang Z, Park WS, Pack S et al. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nat. Genet. 1998; 20; 66-69.
16. Glukhova L, Lavialle C, Fauvet D et al. Mapping of the 7q31 subregion common to the small chromosome 7 derivatives from two sporadic papillary renal cell carcinomas: increased copy number and overexpression of the MET proto-oncogene. Oncogene 2000; 19; 754-761.
17. Choi JS, Kim M, Seo JW et al. MET expression in sporadic renal cell carcinomas. J. Korean Med. Sci. 2006; 21; 672-677.
18. Montesano R, Matslimoto K, Nakamura T, Orci L. Identification of a fibroblast-derived morphogen as hepatocyte growth factor. Cell 1991; 67; 901-908.
19. Fisher E, Pontoglio M. HNF1B and defective nephrogenesis: a role for interacting partners. Kidney Int. 2008; 74; 145-147.
20. Gresh L, Fischer E, Reimann A et al. A transcriptional network in polycystic kidney disease. EMBO J. 2004; 23; 1657-1668.
21. Hiesberger T, Bai Y, Shao X et al. Mutation of hepatocyte nuclear factor-1 beta inhibits Pkhd1 gene expression and produces renal cysts in mice. J. Clin. Invest. 2004; 113; 814-825.
22. Nakayama M, Nozu K, Goto Y et al. HNF1B alterations associated with congenital anomalies of the kidney and urinary tract. Pediatr. Nephrol. 2010; 25; 1073-1079.
23. Dudziak K, Mottalebi N, Senkel S et al. Transcription factor HNF1B and novel partners affect nephrogenesis. Kidney Int. 2008; 74; 210-217.
24. Ma Z, Gong Y, Patel V et al. Mutations of HNF1B inhibit epithelial morphogenesis through dysregulation of SOCS-3. Proc. Natl Acad. Sci. USA 2007; 104; 20386-20391.
25. Kovacs G, Kovacs A. Parenchymal abnormalities associated with papillary renal cell tumors: a morphologic study. J. Urol. Pathol. 1993; 1; 301-312.
26. Kovacs G. Molecular cytogenetics of renal cell tumors. Adv. Cancer Res. 1993; 62; 89-124.
27. Horikawa Y, Iwasaki N, Hara M et al. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat. Genet. 1997; 17; 384-385.
28. Rebouissou S, Vasiliu V, Thomas C et al. Germline hepatocyte nuclear factor 1α and 1β mutations in renal cell carcinomas. Hum. Mol. Genet. 2005; 14; 603-614.
29. Speicher M, Schoel B, duManoir S et al. Specific loss of chromosomes 1, 2, 6, 10, 13, 17 and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridisation. Am. J. Pathol. 1994; 145; 356-364.
30. Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, van KesselAG, Kovacs G. High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer 2009; 9; 152.